Abstract CT231: Identification of a Novel Agnostic Predictive Multiomic Signature Via Elastic Net/Machine Learning in TALAPRO-2 (TP-2), a Phase 3 Study of Talazoparib (TALA) + Enzalutamide (ENZA) Vs Placebo (PBO) + ENZA As First-Line (1L) Treatment in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined